Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
Clinical trial NCT01107717 · COMPLETED
Trial details
- NCT number
- NCT01107717
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2023-02-03
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.